Sanofi Backs off Suggestion that US would Have Priority Access to The Vaccine

The French pharmaceutical CEO was called to the Elysee Palace for a meeting with Emmanuel Macron. At the end of the meeting, the presidency issued a statement saying that Sanofi “shares France’s approach to universal access to a vaccine” for coronavirus.

French pharmaceutical giant Sanofi stepped down this Tuesday in its apparent intentions to give priority to the United States in accessing a vaccine for Covid-19, CNN advances.

Last week, Sanofi’s CEO Paul Hudson said in an interview with Bloomberg that “the United States government has the right to the largest pre-order because it is invested in facing the risk.”

A statement that did not go well with the French government. The Secretary of State for the Economy, Agnes Pannier-Runacher, said that it would be “unacceptable for Sanofi to reserve” the vaccine it is developing for Covid-19 “for one country or another for financial reasons”.

Sanofi responded through a statement last Friday in which it indicated that Hudson’s claims had been misinterpreted.

But its dome did not escape being called to the Elysee Palace. This Tuesday the CEO of Sanofi, Paul Hudson, the president of the pharmaceutical company, Olivier Bogillot, and the chairman of the administration, Serge Weinberg, met with the French president, Emmanuel Macron.

At the end of the meeting, it was the French presidency  confirmed that Sanofi’s retreat in the idea of ​​giving the United States priority access to a vaccine.

Sanofi “confirmed to the president that it shares France’s approach to universal access to a vaccine with the aim of making it a global public good.”

On the part of Sanofi there was no reaction after the meeting at the Elysee Palace.

Reviewer overview

Sanofi Backs off that US would Have Priority Access to The Vaccine - /10

Summary

The French pharmaceutical CEO was called to the Elysee Palace for a meeting with Emmanuel Macron.

0 Bad!